Research Article
BibTex RIS Cite
Year 2021, Volume: 38 Issue: 1, 16 - 20, 26.01.2021

Abstract

References

  • Brinton LA, Blot WJ, Becker JA. A case-Control Study of Cancers of the Nasal Cavity and Paranasal Sinuses. Am J Epidemiol 1994; 6: 896 - 906.
  • Constantino Gde T, Abdo TT, Romano FR, Voegels RL, Butugan O. The role of endoscopic surgery in the treatment of nasal inverted papilloma. Braz J Otorhinolaryngol. 2007; 73(1): 65-68.
  • Frierson HF. Pathologic quiz, case I. Arch Otolaryngol Head Neck Surg. 1986; 112: 568-570.
  • Kitapçı F, Muluk NB, Atasoy P, Koç C. Nazal polpler. Van Tıp Dergisi 2005;12(3): 212-222.
  • Lee CH, Hur DG, Roh HJ, Rha KS, Jin HR, Rhee CS, Min YG. Survival rotes of sinonasal squamous cell carcinoma with the new AJCC staging system. Arch Otolaryngol Head Neck Surg. 2007; 133(2): 131-134.
  • Lund V: Malignant Tumors of the Nasal Cavity and paranasal Sinuses. ORL.45:1-12,1983.
  • Maniglia AJ and David PA. Midfacial degloving for the manegement of nasalsinus and skull-base neoplam –Paranasal sinus Tumors. Otolaryngologic Clinics of Nort America. 1995; 28(6):1127.
  • Thompson LDR, Franchi A. New tumor entities in the 4th edition of the World Health Organization classification of head and neck tumors: Nasal cavity, paranasal sinuses and skull base. Virchows Archiv. 2017; 472(3): 315–330.
  • Tritt S, Mc Mains KC, Kountakis SE. Unilateral nasal polyposis: clinical presentation and pathology. Am J Otolaryngol 2008; 29(4): 230-232.
  • Zhao RW, Guo ZQ, Zhang RX. Human papillomavirus infection and the malinant transformation of sinonasal inverted papilloma: A meta-analysis. Journal of Clinical Virology. 2016; 79: 36-43.

Sinonasal neoplasms: A tertiar center experience

Year 2021, Volume: 38 Issue: 1, 16 - 20, 26.01.2021

Abstract

Primary tumors of the nasal cavity can be classified as benign or malignant. Patients with tumors of the nose and paranasal sinuses are usually diagnosed in the advanced stages of the disease. The aim of this study was to evaluate the data of patients who were operated for sinonasal masses in our clinic in light of the literature. Between January 2016 and December 2018, 357 cases of sinonasal masses presenting to the Otorhinolaryngology Department of the Health Science University at the Samsun Training and Research Hospital were retrospectively screened and included in the study. Of the 357 patients included in the study, 256 (72%) were male, and 101 (28%) were female. The most common symptom was nasal obstruction (90%). Most of the benign cases were nasal polyps (90.2%), while the next most frequent diagnosis was inverted papilloma (4.7%). Malign neoplasms were found in 11 cases, and five were found to be squamous cell carcinomas (SCC). All benign cases were treated surgically, and the malignant cases were treated according to the diagnosis. In conclusion, although the symptoms of the 357 patients with sinonasal mass were similar, histopathological evaluation revealed 96.9% benign and 3.1% malign pathologies. The malign/benign ratio was 3.08. Malignancy should therefore be considered as a possibility in patients with nasal bleeding and facial swelling.

References

  • Brinton LA, Blot WJ, Becker JA. A case-Control Study of Cancers of the Nasal Cavity and Paranasal Sinuses. Am J Epidemiol 1994; 6: 896 - 906.
  • Constantino Gde T, Abdo TT, Romano FR, Voegels RL, Butugan O. The role of endoscopic surgery in the treatment of nasal inverted papilloma. Braz J Otorhinolaryngol. 2007; 73(1): 65-68.
  • Frierson HF. Pathologic quiz, case I. Arch Otolaryngol Head Neck Surg. 1986; 112: 568-570.
  • Kitapçı F, Muluk NB, Atasoy P, Koç C. Nazal polpler. Van Tıp Dergisi 2005;12(3): 212-222.
  • Lee CH, Hur DG, Roh HJ, Rha KS, Jin HR, Rhee CS, Min YG. Survival rotes of sinonasal squamous cell carcinoma with the new AJCC staging system. Arch Otolaryngol Head Neck Surg. 2007; 133(2): 131-134.
  • Lund V: Malignant Tumors of the Nasal Cavity and paranasal Sinuses. ORL.45:1-12,1983.
  • Maniglia AJ and David PA. Midfacial degloving for the manegement of nasalsinus and skull-base neoplam –Paranasal sinus Tumors. Otolaryngologic Clinics of Nort America. 1995; 28(6):1127.
  • Thompson LDR, Franchi A. New tumor entities in the 4th edition of the World Health Organization classification of head and neck tumors: Nasal cavity, paranasal sinuses and skull base. Virchows Archiv. 2017; 472(3): 315–330.
  • Tritt S, Mc Mains KC, Kountakis SE. Unilateral nasal polyposis: clinical presentation and pathology. Am J Otolaryngol 2008; 29(4): 230-232.
  • Zhao RW, Guo ZQ, Zhang RX. Human papillomavirus infection and the malinant transformation of sinonasal inverted papilloma: A meta-analysis. Journal of Clinical Virology. 2016; 79: 36-43.
There are 10 citations in total.

Details

Primary Language English
Subjects Health Care Administration
Journal Section Clinical Research
Authors

Dursun Mehmet Mehel

Abdulkadir Özgür 0000-0002-6155-5988

Samet Aydemir

Mehmet Çelebi

Doğukan Özdemir

Gökhan Akgül

Semih Van

Publication Date January 26, 2021
Submission Date December 17, 2019
Acceptance Date July 1, 2020
Published in Issue Year 2021 Volume: 38 Issue: 1

Cite

APA Mehel, D. M., Özgür, A., Aydemir, S., Çelebi, M., et al. (2021). Sinonasal neoplasms: A tertiar center experience. Journal of Experimental and Clinical Medicine, 38(1), 16-20.
AMA Mehel DM, Özgür A, Aydemir S, Çelebi M, Özdemir D, Akgül G, Van S. Sinonasal neoplasms: A tertiar center experience. J. Exp. Clin. Med. January 2021;38(1):16-20.
Chicago Mehel, Dursun Mehmet, Abdulkadir Özgür, Samet Aydemir, Mehmet Çelebi, Doğukan Özdemir, Gökhan Akgül, and Semih Van. “Sinonasal Neoplasms: A Tertiar Center Experience”. Journal of Experimental and Clinical Medicine 38, no. 1 (January 2021): 16-20.
EndNote Mehel DM, Özgür A, Aydemir S, Çelebi M, Özdemir D, Akgül G, Van S (January 1, 2021) Sinonasal neoplasms: A tertiar center experience. Journal of Experimental and Clinical Medicine 38 1 16–20.
IEEE D. M. Mehel, “Sinonasal neoplasms: A tertiar center experience”, J. Exp. Clin. Med., vol. 38, no. 1, pp. 16–20, 2021.
ISNAD Mehel, Dursun Mehmet et al. “Sinonasal Neoplasms: A Tertiar Center Experience”. Journal of Experimental and Clinical Medicine 38/1 (January 2021), 16-20.
JAMA Mehel DM, Özgür A, Aydemir S, Çelebi M, Özdemir D, Akgül G, Van S. Sinonasal neoplasms: A tertiar center experience. J. Exp. Clin. Med. 2021;38:16–20.
MLA Mehel, Dursun Mehmet et al. “Sinonasal Neoplasms: A Tertiar Center Experience”. Journal of Experimental and Clinical Medicine, vol. 38, no. 1, 2021, pp. 16-20.
Vancouver Mehel DM, Özgür A, Aydemir S, Çelebi M, Özdemir D, Akgül G, Van S. Sinonasal neoplasms: A tertiar center experience. J. Exp. Clin. Med. 2021;38(1):16-20.